Litcius/Paper detail

Interaction between anemia and hyperuricemia in the risk of all-cause mortality in patients with chronic kidney disease

Zhaoxuan Lu, Fangping Lu, Ruixue Zhang, Shuting Guo

2024Frontiers in Endocrinology12 citationsDOIOpen Access PDF

Abstract

Aim: Both hyperuricemia and anemia are not only the manifestation of chronic kidney disease (CKD) but also related to its occurrence and development. A recent study has found that there was a synergetic effect between hyperuricemia and anemia on new-onset CKD. Herein we aimed to explore the roles of hyperuricemia and anemia in the all-cause mortality in patients with CKD. Methods: Data of adult patients with CKD were extracted from the National Health and Nutrition Examination Surveys (NHANES) database in 2009-2018 in this retrospective cohort study. Weighted univariate and multivariate COX regression analyses were used to investigate the associations of hyperuricemia and anemia with all-cause mortality, and the evaluation indexes were hazard ratios (HRs) and 95% confidence intervals (CIs). The interaction effect between hyperuricemia and anemia on the risk of all-cause mortality was assessed via relative excess risk due to interaction (RERI) and attributable proportion of interaction (AP). Subgroup analyses of age, gender, CVD, hypertension, DM, and cancer were also performed to assess this interaction effect. Results: Among 3,678 eligible patients, 819 died from all causes. After adjusting for covariables, we found that CKD patients with anemia (HR = 1.72, 95%CI: 1.42-2.09) or hyperuricemia (HR = 1.21, 95%CI: 1.01-11.45) had a higher risk of all-cause mortality. There was a potential synergetic effect between anemia and hyperuricemia on all-cause mortality, with RERI of 0.630 and AP of 0.291. Moreover, this synergetic effect was also observed in ≥65 years old (AP = 0.330), male (AP = 0.355), hypertension (AP = 0.736), non-hypertension (AP = 0.281), DM (AP = 0.371), and cancer (AP = 0.391) subgroups. Conclusion: A potential synergetic effect between anemia and hyperuricemia on all-cause mortality was found in patients with CKD. However, further studies are needed to clarify the causal relationship between them.

Topics & Concepts

HyperuricemiaMedicineAnemiaKidney diseaseHazard ratioInternal medicineProportional hazards modelNational Health and Nutrition Examination SurveyCohort studyConfidence intervalPopulationUric acidEnvironmental healthGout, Hyperuricemia, Uric AcidDiet, Metabolism, and DiseaseErythropoietin and Anemia Treatment
Interaction between anemia and hyperuricemia in the risk of all-cause mortality in patients with chronic kidney disease | Litcius